Exhibit 10.1 GENES TO LEADS(R) AGREEMENT CENGENT'S LEAD IDENTIFICATION PROGRAM IN DRUG DISCOVERY BASIC TERMS The basic terms of this Genes-to-Leads(R) Agreement ("AGREEMENT") are: 1. Effective Date of Agreement: June 7, 2004. 2. Parties (collectively...AngioGenex, Inc. • January 9th, 2006 • Communications services, nec • California
Exhibit 10.2 GENES TO LEADS(R) AGREEMENT CENGENT'S LEAD IDENTIFICATION PROGRAM IN DRUG DISCOVERY BASIC TERMS The basic terms of this Genes-to-Leads(R) Agreement ("AGREEMENT") are: 1. Effective Date of Agreement: June 6, 2004. 2. Parties (collectively...AngioGenex, Inc. • January 9th, 2006 • Communications services, nec • California
EXCLUSIVE LICENSE AGREEMENT --------------------------- (SK#4771)Exclusive License Agreement • January 9th, 2006 • AngioGenex, Inc. • Communications services, nec • New York
RESEARCH STUDY AGREEMENT This Agreement (the "Agreement") is dated as of September 24, 2001, by and between AngioGenex, Inc., a New York corporation having an office at 825 3rd Avenue, New York, New York 10021 (the "Company"), and Biocheck (the...Research Study Agreement • January 9th, 2006 • AngioGenex, Inc. • Communications services, nec • California
